4502:TYO
Takeda Pharmaceutical Co Ltd
JP¥ ५,७८०.००
०.००%
(०.००) 1D
सेप्टेम्बर ३०, १५:३०:०० GMT+९ · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4502...
Mkt. cap
९२.६० खरब
Avg. vol.
४१.९८ लाख
Volume
०.००
Dividend
३.४६%
Quarterly dividend
JP¥ ५०
Ex-dividend date
२०२६ सेप्टेम्बर २९
52-wk high
JP¥ ६,०३३
52-wk low
JP¥ ४,१०२
EPS
-JP¥ १०३
Shares outstanding
७८.४५ करोड
No. of employees
४७ हजार
Mkt. cap
९२.६० खरब
Avg. vol.
४१.९८ लाख
Volume
०.००
Dividend
३.४६%
Quarterly dividend
JP¥ ५०
Ex-dividend date
२०२६ सेप्टेम्बर २९
52-wk high
JP¥ ६,०३३
52-wk low
JP¥ ४,१०२
EPS
-JP¥ १०३
Shares outstanding
७८.४५ करोड
No. of employees
४७ हजार
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees४७ हजार
Founded१७८१ जुन १२
Headquarters-
Sector-
Websitetakeda.com